Stevanato Group S.p.A (STVN) Gains from Sales and Divestitures (2021 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Gains from Sales and Divestitures came in at $144132.9 in Q2 2026, up 38.33% quarter-over-quarter from $104196.4 in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) Gains from Sales and Divestitures (2021 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Gains from Sales and Divestitures for 6 consecutive years, with $144132.9 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gains from Sales and Divestitures changed N/A year-over-year to $144132.9 in Q2 2026; TTM through Jun 2026 was $256472.5, a N/A change from a year earlier, with the FY2025 full-year figure at -$74498.8, up 13.93% from the prior year.
- Gains from Sales and Divestitures was $144132.9 for Q2 2026 at Stevanato Group S.p.A, up from $104196.4 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $568877.7 in Q3 2024 and troughed at -$729052.9 in Q2 2024.
- A 5-year average of -$34980.4 and a median of -$4155.4 in 2025 frame the typical range for Gains from Sales and Divestitures.
- Across the five-year window, Gains from Sales and Divestitures sank 6754.82% in 2023 and surged 1261.29% in 2024, its largest moves.
- Over 5 years, Gains from Sales and Divestitures stood at -$7141.7 in 2022, then slumped by 6754.82% to -$489552.7 in 2023, then jumped by 106.77% to $33126.5 in 2024, then plunged by 71.89% to $9312.3 in 2025, then jumped by 1447.76% to $144132.9 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $144132.9 (Q2 2026), $104196.4 (Q1 2026), and $9312.3 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 144,132.87 |
| Mar 31, 2026 | 104,196.36 |
| Dec 31, 2025 | 9,312.35 |
| Sep 30, 2025 | -1,169.06 |
| Dec 31, 2024 | 33,126.46 |
| Sep 30, 2024 | 568,877.70 |
| Jun 30, 2024 | -729,052.89 |
| Mar 31, 2024 | 51,059.00 |
| Dec 31, 2023 | -489,552.66 |
| Sep 30, 2023 | -48,986.57 |
| Dec 31, 2022 | -7,141.73 |
| Sep 30, 2022 | -53,438.54 |
| Jun 30, 2022 | -57,621.06 |
| Mar 31, 2022 | -13,468.05 |
| Dec 31, 2021 | -644,055.65 |